Ibrahim A. Al-Nasser

558 total citations
10 papers, 430 citations indexed

About

Ibrahim A. Al-Nasser is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Ibrahim A. Al-Nasser has authored 10 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Ibrahim A. Al-Nasser's work include Mitochondrial Function and Pathology (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cardiac Ischemia and Reperfusion (3 papers). Ibrahim A. Al-Nasser is often cited by papers focused on Mitochondrial Function and Pathology (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cardiac Ischemia and Reperfusion (3 papers). Ibrahim A. Al-Nasser collaborates with scholars based in Saudi Arabia and United Kingdom. Ibrahim A. Al-Nasser's co-authors include M Crompton and Preminda Kessar and has published in prestigious journals such as Biochemical Journal, Toxicology and Toxicology Letters.

In The Last Decade

Ibrahim A. Al-Nasser

10 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ibrahim A. Al-Nasser Saudi Arabia	9	287	78	66	60	54	10	430
Concepción Bravo Mexico	14	317 1.1×	35 0.4×	68 1.0×	59 1.0×	69 1.3×	22	511
Anthony G. Dawson Australia	13	235 0.8×	60 0.8×	127 1.9×	113 1.9×	25 0.5×	28	518
L. Hayat United Kingdom	7	309 1.1×	113 1.4×	54 0.8×	63 1.1×	77 1.4×	10	439
M C Beatrice United States	7	542 1.9×	76 1.0×	187 2.8×	185 3.1×	108 2.0×	8	745
Gaston Ducet France	9	274 1.0×	56 0.7×	65 1.0×	33 0.6×	52 1.0×	22	408
Hui-Zhong Zhou United States	10	359 1.3×	160 2.1×	21 0.3×	62 1.0×	19 0.4×	13	587
Janet C. Ludwig United States	13	149 0.5×	25 0.3×	17 0.3×	83 1.4×	22 0.4×	15	476
Sabine Dalleau France	3	261 0.9×	33 0.4×	24 0.4×	80 1.3×	25 0.5×	3	515
U. Schwabe Germany	12	253 0.9×	30 0.4×	101 1.5×	256 4.3×	50 0.9×	45	577
Miriam Marbach United States	11	260 0.9×	43 0.6×	47 0.7×	34 0.6×	62 1.1×	16	480

Countries citing papers authored by Ibrahim A. Al-Nasser

Since Specialization

Citations

This map shows the geographic impact of Ibrahim A. Al-Nasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim A. Al-Nasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim A. Al-Nasser more than expected).

Fields of papers citing papers by Ibrahim A. Al-Nasser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim A. Al-Nasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim A. Al-Nasser. The network helps show where Ibrahim A. Al-Nasser may publish in the future.

Co-authorship network of co-authors of Ibrahim A. Al-Nasser

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim A. Al-Nasser. A scholar is included among the top collaborators of Ibrahim A. Al-Nasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim A. Al-Nasser. Ibrahim A. Al-Nasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Al-Nasser, Ibrahim A. & Ibrahim A. Al-Nasser. (2000). Cadmium Hepatotoxicity and Alterations of the Mitochondrial Function. Journal of Toxicology Clinical Toxicology. 38(4). 407–413. 50 indexed citations

Al-Nasser, Ibrahim A.. (2000). Ibuprofen-induced liver mitochondrial permeability transition. Toxicology Letters. 111(3). 213–218. 31 indexed citations

Al-Nasser, Ibrahim A.. (1999). Salicylate-induced kidney mitochondrial permeability transition is prevented by cyclosporin A. Toxicology Letters. 105(1). 1–8. 30 indexed citations

Al-Nasser, Ibrahim A.. (1998). In vivo prevention of cyclophosphamide-induced Ca2+ dependent damage of rat heart and liver mitochondria by cyclosporin A. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 121(3). 209–214. 26 indexed citations

Al-Nasser, Ibrahim A.. (1998). In vivo prevention of adriamycin cardiotoxicity by cyclosporin A or FK506. Toxicology. 131(2-3). 175–181. 26 indexed citations

Al-Nasser, Ibrahim A., et al.. (1996). Renal insufficiency induced by cisplatin in rats is ameliorated by cyclosporin A. Toxicology. 114(1). 11–17. 17 indexed citations

Al-Nasser, Ibrahim A., et al.. (1995). Dexamethasone inhibits inorganic phosphate stimulated Ca2+-dependent damage of isolated rat liver and renal cortex mitochondria. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 111(2). 221–225. 1 indexed citations

Al-Nasser, Ibrahim A. & M Crompton. (1986). The reversible Ca2+-induced permeabilization of rat liver mitochondria. Biochemical Journal. 239(1). 19–29. 151 indexed citations

Al-Nasser, Ibrahim A. & M Crompton. (1986). The entrapment of the Ca2+ indicator arsenazo III in the matrix space of rat liver mitochondria by permeabilization and resealing. Na+-dependent and -independent effluxes of Ca2+ in arsenazo III-loaded mitochondria. Biochemical Journal. 239(1). 31–40. 36 indexed citations

10.

Crompton, M, Preminda Kessar, & Ibrahim A. Al-Nasser. (1983). The α-adrenergic-mediated activation of the cardiac mitochondrial Ca2+ uniporter and its role in the control of intramitochondrial Ca2+in vivo. Biochemical Journal. 216(2). 333–342. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact